Cargando…
Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia
BACKGROUND: Rewarming from hypothermia is associated with severe complications, one of which is hypothermia-induced cardiac dysfunction. This condition is characterized by decreased cardiac output accompanied by increased total peripheral resistance. This contributes to mortality rate approaching 40...
Autores principales: | Selli, Anders Lund, Kuzmiszyn, Adrina Kalasho, Smaglyukova, Natalia, Kondratiev, Timofey, Fuskevåg, Ole-Martin, Sager, Georg, Dietrichs, Erik Sveberg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756503/ https://www.ncbi.nlm.nih.gov/pubmed/36522632 http://dx.doi.org/10.1186/s13049-022-01060-y |
Ejemplares similares
-
Treatment of Cardiovascular Dysfunction With PDE5-Inhibitors – Temperature Dependent Effects on Transport and Metabolism of cAMP and cGMP
por: Selli, Anders L., et al.
Publicado: (2021) -
Treatment of Cardiovascular Dysfunction with PDE3-Inhibitors in Moderate and Severe Hypothermia—Effects on Cellular Elimination of Cyclic Adenosine Monophosphate and Cyclic Guanosine Monophosphate
por: Kuzmiszyn, Adrina Kalasho, et al.
Publicado: (2022) -
Cardiovascular Effects of Epinephrine During Experimental Hypothermia (32°C) With Spontaneous Circulation in an Intact Porcine Model
por: Mohyuddin, Rizwan, et al.
Publicado: (2021) -
Altered pharmacological effects of adrenergic agonists during hypothermia
por: Dietrichs, Erik Sveberg, et al.
Publicado: (2016) -
Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux
por: Subbotina, Anna, et al.
Publicado: (2017)